Colchicine for Prevention of Atherothrombotic Events in Patients With Coronary Artery Disease: Review and Practical Approach for Clinicians
- 1 November 2021
- journal article
- review article
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 37 (11) , 1837-1845
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Technical Advance: Inhibition of neutrophil chemotaxis by colchicine is modulated through viscoelastic properties of subcellular compartmentsJournal of Leukocyte Biology, 2013
- Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic PatientsJACC, 2013
- Colchicine for Prevention of Early Atrial Fibrillation Recurrence After Pulmonary Vein IsolationJACC, 2012
- A Prospective Natural-History Study of Coronary AtherosclerosisNew England Journal of Medicine, 2011
- Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and InflammationPLOS ONE, 2010
- Inflammatory response to percutaneous coronary intervention in stable coronary artery diseaseJournal of Thrombosis and Thrombolysis, 2010
- Effect of Colchicine (0.5 mg Twice Daily) on High-Sensitivity C-Reactive Protein Independent of Aspirin and Atorvastatin in Patients With Stable Coronary Artery DiseaseThe American Journal of Cardiology, 2007
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplastyJACC, 1996
- Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils.Journal of Clinical Investigation, 1995